New Method to Alleviate Shortage of Plasma Therapies
- By BSTQ Staff
Plasma Tech Biopharmaceuticals has developed a new and innovative method to extract plasma proteins from pooled human plasma samples in order to alleviate the potential shortage of available plasma-based therapies. Currently, the Cohn Cold fractionation process has been the most common protocol for plasma protein extraction since its inception in the 1940s, with an extraction rate of 7 percent from blood (with plasma concentration of 1.8 grams to 3.5 grams per liter). The new method, called the Optimized Plasma Process, increases the yield by ten-fold, recovering almost 70 percent of plasma. The technique is expected to be helpful for increasing the availability of plasma therapies to treat immune disorders, autoimmune disease, neuropathies and a host of other diseases currently being researched.
